Related Experiment Videos

Differential regulation of choriocarcinoma gene expression by DNA synthesis inhibitors

J L Arbiser1, Z K Arbiser, J A Majzoub

  • 1Division of Endocrinology, Children's Hospital, Boston, MA 02115.

Endocrine Journal
|April 1, 1993
PubMed

Insights

Downregulating c-myc oncogene expression alone is insufficient to induce all placental genes. Methotrexate (MTX) and other drugs show varied effects on gene expression in BeWo cells.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Gene expression regulation

Background:

  • Methotrexate (MTX) and hydroxyurea (HU) previously shown to induce placental genes (hCG alpha, PLAP) and repress c-myc in BeWo cells.
  • The role of c-myc downregulation in MTX-induced placental gene expression remains unclear.

Purpose of the Study:

  • To investigate if c-myc downregulation is sufficient for inducing placental-specific gene expression.
  • To compare the effects of aphidicolin (APH) and 6-diazo-5-oxo-L-norleucine (DON) with MTX on gene expression and cellular morphology in BeWo cells.

Main Methods:

  • Treatment of BeWo choriocarcinoma cells with MTX, APH, and DON.
  • Analysis of c-myc, hCG alpha, placental alkaline phosphatase (PLAP), and cholesterol side chain cleavage enzyme gene expression.
  • Observation of morphological changes in BeWo cells.

Main Results:

  • APH and DON, like MTX, downregulated c-myc expression and induced similar morphological changes.
  • Neither APH nor DON stimulated hCG alpha expression.
  • DON and APH stimulated PLAP expression, while MTX and DON stimulated cholesterol side chain cleavage enzyme expression.

Conclusions:

  • c-myc downregulation is necessary but not sufficient for the induction of all placental genes by MTX.
  • Different drugs can induce specific placental genes through distinct pathways, independent of c-myc repression.

Related Concept Videos